Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules

Clinical and Experimental Immunology

Volumn 161, Issue 1, 2010, Pages 81-88

  McMullen, T P W ^a   Lai, R ^b   Dabbagh, L ^b   Wallace, T M ^a   De Gara, C J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Dendritic cell; Lymphoid nodule; Rectal cancer; T cell

Indexed keywords

CD83 ANTIGEN; T6 ANTIGEN;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CELL AGGREGATION; CELL DENSITY; CELL LEVEL; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; RECTUM CANCER; T LYMPHOCYTE; TISSUE DISTRIBUTION;

ADENOCARCINOMA; AGED; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD3; DENDRITIC CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTESTINAL MUCOSA; KAPLAN-MEIERS ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOID TISSUE; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECTAL NEOPLASMS; T-LYMPHOCYTE SUBSETS;

EID: 77953266601     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04147.x     Document Type: Article

References (38)

1. Gattaj G, Ciccolallo L. Differences in colorectal cancer survival between European and US populations: The importance of sub-site and morphology. Eur J Cancer 2003 39 : 2214 2222.
2. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: An update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 1999 85 : 1670 1676.
3. Manfredi S, Benhamiche AM, Meny B et al. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg 2001 88 : 1221 1227.
4. Rajput A, Bullard Dunn K. Surgical management of rectal cancer. Semin Oncol 2007 34 : 241 249.
5. Gilboa EJ. Dendritic cell-based cancer vaccines. Clin Invest 2007 117 : 1195 1203.
6. Mosca PJ, Lyerly HK, Clay TM et al. Dendritic cell vaccines. Front Biosci 2007 12 : 4050 4060.
7. Nagorsen D, Thiel E. Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer. Clin Cancer Res 2006 12 : 3064 3069.
8. Jass JR. Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol 1986 39 : 585 589.
9. Kreider JW, Bartlett GL, Butkiewicz BL. Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis. Cancer Metastasis Rev 1984 3 : 53 74.
10. Talmadge JE, Donkor M, Scholar E. Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 2007 26 : 373 400.
11. Waldner M, Schimanski CC, Neurath MF. Colon cancer and the immune system: The role of tumor invading T cells. World J Gastroenterol 2006 12 : 7233 7238.
12. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature 1998 392 : 245 522.
13. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 2007 5 : 62 70.
14. Bell SJ, Rigby R, English N et al. Migration and maturation of human colonic dendritic cells. J Immunol 2001 166 : 4958 4967.
15. Celluzi C, Falo L. Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection. J Immunol 1998 160 : 3081 3085.
16. Ambe K, Mori M, Enjoji M. S-100 protein positive cells in colorectal adenocarcinomas. Cancer 1989 63 : 496 503.
17. Dadabayev AR, Sandel MH, Menon AG et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother 2004 53 : 978 986.
18. Sandel MH, Dadabayev AR, Menon AG et al. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization. Clin Cancer Res 2005 11 : 2576 2582.
19. Schwaab T, Weiss JE, Schned AR et al. Dendritic cell infiltration in colon cancer. J Immunother 2001 24 : 130 137.
20. Suzuki A, Masuda A, Nagata H et al. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 2002 196 : 37 43.
21. Chiba T, Ohtani H, Mizoi T et al. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: Possible association with suppression of micrometastasis. Br J Cancer 2004 91 : 1711 1717.
22. Funada Y, Noguchi T, Kikuchi R et al. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 2003 10 : 309 313.
23. Koch M, Beckhove P, Op den Winkel J et al. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ. Ann Surg 2006 244 : 986 992.
24. Musha H, Ohtani H, Mizoi T et al. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma. Int J Cancer 2005 116 : 949 956.
25. Naito Y, Saito K, Shiiba K et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998 58 : 3491 3494.
26. O'Learly AD, Sweeney EC. Lymphoglandular complexes of the colon: Structure and distribution. Histopathology 1986 10 : 267 283.
27. Prall F, Dührkop T, Weirich V et al. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. Hum Pathol 2004 35 : 808 816.
28. Sandel MH, Speetjens FM, Menon AG et al. Natural killer cells infiltrating colorectal cancer and MHC class I expression. Mol Immunol 2005 42 : 541 546.
29. Takemoto N, Konishi F, Yamashita K et al. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: The significance of different types of lymphocyte infiltration. Jpn J Clin Oncol 2004 34 : 90 8.
30. Cameron IL, Kent JE, Philo R et al. Numerical distribution of lymphoid nodules in the human sigmoid colon, rectosigmoidal junction, rectum and anal canal. Clin Anat 2006 19 : 164 170.
31. Dukes C, Bussey HJR. The number of lymphoid follicles of the human large intestine. J Pathol Bacteriol 1926 29 : 111 116.
32. Ménétrier-Caux C, Gobert M, Caux C. Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res 2009 69 : 7895 7898.
33. Langman JM, Rowland R. The number and distribution of lymphoid follicles in the human large intestine. J Anat 1986 194 : 189 194.
34. Nascimbeni R, Di Fabio F, Di Betta E et al. Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol 2005 18 : 681 685.
35. Hui D, Reiman T, Hanson J et al. Immunohistochemical detection of cdc2 is useful in predicting survival in patients with mantle cell lymphoma. Mod Pathol 2005 18 : 1223 1231.
36. Galon J, Costes A, Sanchez-Cabo F et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006 313 : 1960 1964.
37. Pagès F, Berger A, Camus M et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005 353 : 2654 2666.
38. Menon AG, Janssen-van Rhijn CM, Morreau H et al. Immune system and prognosis in colorectal cancer: A detailed immunohistochemical analysis. Lab Invest 2004 84 : 493 501.